Noticias de investigación
Ver artículos por meses y años
1–6 of 6 artículos
-
Drug May Boost Survival in Metastatic Breast Cancer (en inglés)
Women diagnosed with metastatic breast cancer that had stopped responding or failed to respond to other treatments lived 2 months longer when treated with Halavan (chemical name: eribulin) compared to ...
-
FDA Approves Drug for Pretreated Breast Cancer (en inglés)
The U.S. Food and Drug Administration (FDA) has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemo...
-
ASCO Breast: Analysis Revises Taxane Benefit in Breast Cancer (en inglés)
After surgery for early-stage breast cancer, chemotherapy often is given to destroy any breast cancer cells that may remain in the body and reduce the risk of the cancer coming back (recurrence). Docto...
-
New Chemotherapy Agents Cut Advanced Breast Cancer Mortality in Half (en inglés)
Research has made it clear that new ways to treat and diagnose breast cancer have benefitted women diagnosed with early-stage breast cancer. Women diagnosed with advanced-stage breast cancer also have ...
-
New Therapies Vie for Role in Breast Cancer (en inglés)
Researchers are continually working to find better ways to treat all stages of breast cancer. Several studies offer very early results on a number of new ways to treat breast cancer. The results were r...
-
Breast cancer survival longer with Taxotere: study (en inglés)
The combination of two chemotherapy medicines, Adriamycin (chemical name: doxorubicin) and Cytoxan (chemical name: cyclophosphamide), often referred to as AC, is commonly used after surgery to treat an...
1–6 of 6 artículos
